GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain; glutamate is the primary excitatory neurotransmitter. GABA receptors (GABA-A and GABA-B) hyperpolarize neurons; glutamate receptors (ionotropic and metabotropic) depolarize and modulate plasticity. Most psychoactive drugs target these systems: benzodiazepines enhance GABA-A function; hallucinogens modulate glutamate receptors.
Think of the nervous system as a vast conversation happening simultaneously across billions of neurons. Most of that conversation is conducted in just two languages: glutamate says "fire" and GABA (gamma-aminobutyric acid) says "stop." You already understand from your prerequisite work on inhibitory-excitatory balance that every neuron sits at the intersection of push-and-pull signals. Glutamate and GABA are the chemical agents carrying those signals across the majority of synapses in the brain — they are not minor players but the primary infrastructure of neural communication.
Glutamate acts through two major receptor families. Ionotropic glutamate receptors — AMPA and NMDA — are ion channels that open directly when glutamate binds, letting sodium (and in the case of NMDA, calcium) flood into the postsynaptic cell and depolarizing it toward firing threshold. NMDA receptors are especially important because they require both ligand binding and membrane depolarization to open fully — a coincidence detection mechanism that underlies synaptic plasticity and learning. Metabotropic glutamate receptors work more slowly through G-proteins, modulating neuronal excitability over longer time scales. GABA works in the opposite direction: GABA-A receptors are chloride channels that hyperpolarize the neuron when open, making it harder to fire. GABA-B receptors are metabotropic and activate potassium channels, producing a slower, more sustained inhibition.
This glutamate/GABA balance is not static — it is dynamically regulated across brain regions and moments. Runaway excitation produces excitotoxicity: too much glutamate floods neurons with calcium, triggering cell death (this is what happens in stroke). Runaway inhibition suppresses consciousness (this is how general anesthetics work). The brain's goal is a tight homeostatic balance. Interneurons — small local GABA-releasing neurons — serve as the circuit breakers of cortical networks, ensuring excitation never cascades uncontrolled.
Understanding these two systems explains a large fraction of pharmacology. Benzodiazepines (like diazepam) are positive allosteric modulators of GABA-A receptors: they don't activate the receptor directly but increase the frequency with which the chloride channel opens in response to GABA, amplifying inhibition. This produces anxiolysis, sedation, muscle relaxation, and anticonvulsant effects — all predictable from enhanced GABAergic tone. Alcohol works similarly. Anesthetics like propofol also target GABA-A. On the glutamate side, ketamine blocks NMDA receptors, which at low doses produces dissociation and at high doses full anesthesia; phencyclidine (PCP) does the same. The hallucinogen effects of these drugs follow directly from disrupting the brain's primary excitatory system, particularly in circuits encoding self-model and sensory integration.